Clinical Data Completes Acquisition Of Genaissance Pharmaceuticals, Inc. (GNSC)
10/19/2005 5:13:19 PM
More...
|
Genaissance Pharmaceuticals, Inc. (GNSC) And ParAllele Bioscience, Inc. Sign License And Co-Marketing Agreement
10/19/2005 5:13:13 PM
More...
|
Genaissance Pharmaceuticals, Inc. (GNSC) To Present At CIBC World Markets Annual Biotechnology And Specialty Pharmaceuticals Conference
10/19/2005 5:13:10 PM
More...
|
Genaissance Pharmaceuticals, Inc. (GNSC) Comments On FDA Guidance On Pharmacogenomics
10/19/2005 5:13:06 PM
More...
|
Genaissance Pharmaceuticals, Inc. (GNSC) Allowed Patent For Method Of Testing Individuals For Genetic Predisposition To Reduced Metabolism Of Drugs
10/19/2005 5:13:00 PM
More...
|
Genaissance Pharmaceuticals, Inc. (GNSC) And Monsanto Company (MON) Team Up With The USDA To Map Soybean Genome
10/19/2005 5:12:58 PM
More...
|
Genaissance Pharmaceuticals, Inc.'s (GNSC) New DNA Test; FAMILION(TM) - Becoming Key Tool For Detecting Long QT Syndrome, A Potentially Fatal Cardiac Disorder
10/19/2005 5:12:44 PM
More...
|
Genaissance Pharmaceuticals, Inc. (GNSC) Reports 2004 Results
10/19/2005 5:12:41 PM
More...
|
Genaissance Pharmaceuticals, Inc. (GNSC) Invites You To Participate In Its Fourth Quarter 2004 Conference Call
10/19/2005 5:12:37 PM
More...
|
Genaissance Pharmaceuticals, Inc. (GNSC) Obtains License To Vanderbilt Patent Linking Genetics To Key Drug Safety Issue
10/19/2005 5:12:33 PM
More...
|
|